Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer

SIMPLE SUMMARY: Identifying which men at the time of prostate cancer diagnosis have, or will progress to, an aggressive fatal disease will allow clinicians to assist men in making better informed treatment decisions. This will not only be important for those men whose disease is likely to remain ind...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Nguyen-Dumont, Tú, Dowty, James G., MacInnis, Robert J., Steen, Jason A., Riaz, Moeen, Dugué, Pierre-Antoine, Renault, Anne-Laure, Hammet, Fleur, Mahmoodi, Maryam, Theys, Derrick, Tsimiklis, Helen, Severi, Gianluca, Bolton, Damien, Lacaze, Paul, Sebra, Robert, Schadt, Eric, McNeil, John, Giles, Graham G., Milne, Roger L., Southey, Melissa C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036662/
https://ncbi.nlm.nih.gov/pubmed/33804961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071495
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller